Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosis
Titel:
Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosis
Auteur:
Knudsen, Maria Højberg Lindberg, Ulrich Frederiksen, Jette Lautrup Vestergaard, Mark Bitsch Simonsen, Helle Juhl Varatharaj, Aravinthan Galea, Ian Blinkenberg, Morten Sellebjerg, Finn Larsson, Henrik Bo Wiberg Cramer, Stig Præstekjær